SCHEMBL5883329

SCHEMBL5883329

CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccncn1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 16/20 0.76
RXRA P19793 2/20 0.68
RARG P13631 1/20 0.68
PPARA Q07869 3/20 0.67
CYP3A4 P08684 2/20 0.51
FFAR1 O14842 3/20 0.50
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
HRH3 Q9Y5N1 1/20 0.48
MPC2 O95563 1/20 0.48
CYP2C8 P10632 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rosiglitazone SCHEMBL5169 0.87 PPARG (1.00) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL11957687 0.87 PPARG (1.00) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL29530259 0.87 PPARG (1.00) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL7052472 0.87 PPARG (1.00) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL2355017 0.87 PPARG (1.00) PPARGRXRARARGPPARACYP3A4
SCHEMBL5883617 0.86 PPARG (0.75) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL1489117 0.86 PPARG (0.98) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL5468691 0.86 PPARG (0.98) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL3377103 0.86 PPARG (0.98) PPARGRXRARARGPPARACYP3A4
Rosiglitazone SCHEMBL6976956 0.86 PPARG (0.98) PPARGRXRARARGPPARACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001910-B1 Thiazolidinedione derivatives as antidiabetic agents VITA-INVEST S.A. (ES) 2006-02-21 US claimed
EP-1231211-B1 THIAZOLIDINEDIONE DERIVATIVES AS ANTIDIABETIC AGENTS VITA INVEST SA (ES) 2003-05-28 EP claimed
EP-1231211-A1 THIAZOLIDINEDIONE DERIVATIVES AS ANTIDIABETIC AGENTS VITA-INVEST, S.A. (ES) 2002-08-14 EP claimed
US-7001910-B1 Thiazolidinedione derivatives as antidiabetic agents VITA-INVEST S.A. (ES) 2006-02-21 US disclosed
EP-1231211-B1 THIAZOLIDINEDIONE DERIVATIVES AS ANTIDIABETIC AGENTS VITA INVEST SA (ES) 2003-05-28 EP disclosed
EP-1231211-A1 THIAZOLIDINEDIONE DERIVATIVES AS ANTIDIABETIC AGENTS VITA-INVEST, S.A. (ES) 2002-08-14 EP disclosed